Analyst Reco. Exact Sciences Corporation

Equities

EXAS

US30063P1057

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 01:40:23 2024-12-11 pm EST			5-day change	1st Jan Change
63.62 ^USD	+3.32%		-1.08%	-14.23%

Dec. 04	Exact Sciences Corporation Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-04-2024 07:30 AM
Dec. 03	Exact Sciences Corporation Presents at Citi's 2024 Global Healthcare Conference, Dec-03-2024 08:45 AM

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Raises Price Target on Exact Sciences to $75 From $65, Maintains Buy Rating	Nov. 26	MT
Analyst recommendations: Snap, Qualys, Sirius XM, Super Micro Computer, Burberry...	Nov. 06
Analyst recommendations: 3M Company, GM, IBM, Robinhood, Moonpig...	Oct. 29
Wells Fargo Global Initiates Exact Sciences at Overweight With $75 Price Target	Aug. 28	MT
UBS Cuts Exact Sciences' Price Target to $61 From $66, Maintains Neutral Rating	Aug. 01	MT
Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target	Jun. 27	MT
BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating	Jun. 26	MT
Benchmark Upgrades Exact Sciences to Buy From Hold, Sets Price Target at $91	Jan. 02	MT
Goldman Sachs Adjusts Price Target on Exact Sciences to $90 From $100, Keeps Buy Rating	Nov. 03	MT
BofA Securities Cuts Price Target on Exact Sciences to $88 From $110, Maintains Buy Rating	23-10-20	MT
Piper Sandler Upgrades Exact Sciences to Overweight From Neutral, Price Target is $90	23-10-10	MT
Bernstein Starts Exact Sciences With Outperform Rating	23-09-28	MT
Baird Adjusts Price Target on Exact Sciences to $121 From $99, Maintains Outperform Rating	23-08-02	MT
Benchmark Downgrades Exact Sciences to Hold From Buy	23-08-02	MT
Credit Suisse Adjusts Exact Sciences' Price Target to $90 From $75, Keeps Neutral Rating	23-08-02	MT
Goldman Sachs Adjusts Price Target on Exact Sciences to $110 From $85, Maintains Buy Rating	23-07-21	MT
UBS Raises Exact Sciences' Price Target to $99 From $73, Maintains Neutral Rating	23-06-27	MT
Canaccord Genuity Raises Price Target on Exact Sciences to $115 From $92, Maintains Buy Rating	23-06-23	MT
Analyst recommendations: BAE Systems, Berkeley, Burberry, Reinsurance Group, Tesla...	23-06-23
Citigroup Adjusts Price Target on Exact Sciences to $130 From $100, Keeps Buy Rating	23-06-22	MT
Jefferies Raises Exact Sciences' Price Target to $100 From $82, Maintains Buy Rating	23-06-07	MT
Citigroup Adjusts Price Target on Exact Sciences to $100 From $90, Maintains Buy Rating	23-05-11	MT
Baird Adjusts Price Target on Exact Sciences to $99 From $92, Maintains Outperform Rating	23-05-10	MT
BofA Adjusts Price Target on Exact Sciences to $88 From $80, Keeps Buy Rating	23-05-10	MT
Credit Suisse Raises Exact Sciences' PT to $75 From $70, Notes Broad-based Momentum, Guide Upgrade; Keeps Neutral Rating	23-05-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Exact Sciences Corporation

Equities

EXAS

US30063P1057

Biotechnology & Medical Research

Analyst Reco.

Filters